Today Health Canada issued the update, Health Canada informing Canadians of risks related to certain preservatives in cosmetic, non-prescription and natural health products.
Health Canada is informing consumers of potential risks related to the combination of methylisothiazolinone and methylchloroisothiazolinone (MI/MCI) used as a preservative in certain leave-on cosmetic, non-prescription and natural health products. Examples of leave-on products include skin moisturizers, massage products, make-up, antiperspirants/deodorants, sunscreen lotions, antiseptic cleansers, topical pain relief, acne creams and diaper rash products.
For some people, use of these substances can lead to symptoms including:
- a red rash or bumps;
- itching (which may be severe);
- swelling, burning, or tenderness of the skin;
- dry, cracked or scaly skin; and/or
- blisters (draining fluid and crusting).
These symptoms may occur each time someone uses a product containing MI/MCI and may become more severe with repeated use.
These preservatives are also used in rinse-off products, such as shampoos and shower gels. Based on current information, there are no identified risks with the use of MI/MCI in rinse-off products when concentrations are at or below levels currently permitted in cosmetics.
For more information about the update, Health Canada informing Canadians of risks related to certain preservatives in cosmetic, non-prescription and natural health products, please visit the Health Canada link above. Please visit Nexreg for more information about Cosmetic Labelling.